Literature DB >> 33352660

Enantiomeric Resolution and Absolute Configuration of a Chiral δ-Lactam, Useful Intermediate for the Synthesis of Bioactive Compounds.

Roberta Listro1, Giacomo Rossino1, Serena Della Volpe1, Rita Stabile1, Massimo Boiocchi2, Lorenzo Malavasi3, Daniela Rossi1, Simona Collina1.   

Abstract

During the past several years, the frequency of discovery of new molecular entities based on γ- or δ-lactam scaffolds has increased continuously. Most of them are characterized by the presence of at least one chiral center. Herein, we present the preparation, isolation and the absolute configuration assignment of enantiomeric 2-(4-bromophenyl)-1-isobutyl-6-oxopiperidin-3-carboxylic acid (trans-1). For the preparation of racemic trans-1, the Castagnoli-Cushman reaction was employed. (Semi)-preparative enantioselective HPLC allowed to obtain enantiomerically pure trans-1 whose absolute configuration was assigned by X-ray diffractometry. Compound (+)-(2R,3R)-1 represents a reference compound for the configurational study of structurally related lactams.

Entities:  

Keywords:  X-ray diffraction; absolute configuration assignment; chiral resolution; enantioselective HPLC; lactam scaffold

Mesh:

Substances:

Year:  2020        PMID: 33352660      PMCID: PMC7766352          DOI: 10.3390/molecules25246023

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  51 in total

1.  The Exploration of Chirality for Improved Druggability within the Human Kinome.

Authors:  Debasmita Saha; Anupreet Kharbanda; Wei Yan; Naga Rajiv Lakkaniga; Brendan Frett; Hong-Yu Li
Journal:  J Med Chem       Date:  2019-10-09       Impact factor: 7.446

Review 2.  Role of Chirality in Drugs: An Overview.

Authors:  Hourieh Alkadi; Rajwa Jbeily
Journal:  Infect Disord Drug Targets       Date:  2018

3.  The role of chirality in a set of key intermediates of pharmaceutical interest, 3-aryl-substituted-γ-butyrolactones, evidenced by chiral HPLC separation and by chiroptical spectroscopies.

Authors:  Daniela Rossi; Rita Nasti; Simona Collina; Giuseppe Mazzeo; Simone Ghidinelli; Giovanna Longhi; Maurizio Memo; Sergio Abbate
Journal:  J Pharm Biomed Anal       Date:  2017-01-05       Impact factor: 3.935

4.  The condensation of succinic anhydride with benzylidinemethylamine. A stereoselective synthesis of trans- and cis-1-methyl-4-carbosy-5-phenyl-2-pyrrolidinone.

Authors:  N Castagnoli
Journal:  J Org Chem       Date:  1969-10       Impact factor: 4.354

Review 5.  RNA-binding proteins as molecular links between cancer and neurodegeneration.

Authors:  Danae Campos-Melo; Cristian A Droppelmann; Kathryn Volkening; Michael J Strong
Journal:  Biogerontology       Date:  2014-09-18       Impact factor: 4.277

6.  Natural α-methylenelactam analogues: Design, synthesis and evaluation of α-alkenyl-γ and δ-lactams as potential antifungal agents against Colletotrichum orbiculare.

Authors:  Wang Delong; Wang Lanying; Wu Yongling; Song Shuang; Feng Juntao; Zhang Xing
Journal:  Eur J Med Chem       Date:  2017-02-22       Impact factor: 6.514

7.  Exploration of ligand binding modes towards the identification of compounds targeting HuR: a combined STD-NMR and Molecular Modelling approach.

Authors:  Francesca Vasile; Serena Della Volpe; Francesca Alessandra Ambrosio; Giosuè Costa; M Yagiz Unver; Chiara Zucal; Daniela Rossi; Emanuela Martino; Alessandro Provenzani; Anna K H Hirsch; Stefano Alcaro; Donatella Potenza; Simona Collina
Journal:  Sci Rep       Date:  2018-09-13       Impact factor: 4.379

Review 8.  A Structure-Based Drug Discovery Paradigm.

Authors:  Maria Batool; Bilal Ahmad; Sangdun Choi
Journal:  Int J Mol Sci       Date:  2019-06-06       Impact factor: 5.923

9.  Use of intensity quotients and differences in absolute structure refinement.

Authors:  Simon Parsons; Howard D Flack; Trixie Wagner
Journal:  Acta Crystallogr B Struct Sci Cryst Eng Mater       Date:  2013-05-17

Review 10.  Lenalidomide as a disease-modifying agent in patients with del(5q) myelodysplastic syndromes: linking mechanism of action to clinical outcomes.

Authors:  Aristoteles Giagounidis; Ghulam J Mufti; Pierre Fenaux; Ulrich Germing; Alan List; Kyle J MacBeth
Journal:  Ann Hematol       Date:  2013-09-10       Impact factor: 3.673

View more
  1 in total

1.  Anti-Multiple Myeloma Potential of Secondary Metabolites from Hibiscus sabdariffa-Part 2.

Authors:  Alessio Malacrida; Valeria Cavalloro; Emanuela Martino; Giosuè Costa; Francesca Alessandra Ambrosio; Stefano Alcaro; Roberta Rigolio; Arianna Cassetti; Mariarosaria Miloso; Simona Collina
Journal:  Molecules       Date:  2021-10-31       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.